Seed · Healthtech · London, United Kingdom · Founded 2023 · 1–10 employees
Verisian develops AI-powered software infrastructure to automate clinical trial analysis, validation, and regulatory submission documentation. The platform links study specifications, underlying data, and code to deliver real-time validation and full traceability for pharmaceutical sponsors, CROs, and regulators. By streamlining artifacts such as SDTM, ADaM, define-XMLs, and CSR generation, the company significantly accelerates time-to-submission for clinical trials. Founded in 2023, the startup secured a $4M Seed funding round in May 2025 to scale its regulatory infrastructure technology.
No open roles listed right now.